Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Opioid-Induced Constipation 5Neoplasms 2Constipation 2Urinary Bladder Neoplasms 1Pain 1Carcinoma, Non-Small-Cell Lung 1Cancer Pain 1

Interventions

Morphine 15Oxycodone 13Fentanyl 9nabiximols 5Methadone 5Lidocaine 5Acetaminophen 5resiniferatoxin 4Ethanol 4Acupuncture Therapy 4Transcutaneous Electric Nerve Stimulation 3Hydromorphone 3Transcranial Direct Current Stimulation 2Surveys and Questionnaires 2Standard of Care 2Sodium Bicarbonate 2Radiofrequency Ablation 2Pharmaceutical Services 2Naloxone 2Ketamine 2Electroacupuncture 2Dronabinol 2Control Groups 2Buprenorphine 2Analgesics, Opioid 26'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine 2tanezumab 1rofecoxib 1naloxegol 1incobotulinumtoxinA 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Cancer Pain × naloxegol × Clear all
NCT01384292 2015-06-01

Assessment of Efficacy and Safety in Relieving Opioid-induced Constipation in Patients With Cancer-related Pain

AstraZeneca

Phase 3 Terminated
14 enrolled 7 charts
Other

Cancer Pain, Opioid-Induced Constipation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡